• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Transcode Therapeutics Inc (NQ: RNAZ )

    0.2699 +0.0033 (+1.24%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 783,819
    Open 0.2618
    Bid (Size) 0.2600 (38)
    Ask (Size) 0.2800 (29)
    Prev. Close 0.2666
    Today's Range 0.2576 - 0.2749
    52wk Range 0.2160 - 104.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    RNAZ Stock Earnings: TransCode Therapeutics Misses EPS for Q2 2024
    RNAZ stock results show that TransCode Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    TransCode Therapeutics Announces Phase 1 Clinical Trial Initiation
    From TransCode Therapeutics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -95.82%
    -95.82%
    1 Month
    -65.94%
    -65.94%
    3 Month
    -77.32%
    -77.32%
    6 Month
    -60.25%
    -60.25%
    1 Year
    -99.59%
    -99.59%

    More News

    Read More
    Why Pitney Bowes Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    TransCode Therapeutics, Inc. Announces Closing of Public Offering
    From TransCode Therapeutics, Inc.
    Via GlobeNewswire
    Gold Moves Higher; Coca-Cola Increases FY24 Forecast
    Via Benzinga
    Why Transcode Therapeutics (RNAZ) Stock Is Down 60%
    Via Benzinga
    Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Crude Oil Down 2%; GE Aerospace Earnings Top Views
    Via Benzinga
    Exposures Fossil Fuels
    US Stocks Edge Higher; General Motors Posts Upbeat Earnings
    Via Benzinga
    Why Is Mira Pharmaceuticals (MIRA) Stock Down 27% Today?
    Via InvestorPlace
    Why Is TransCode Therapeutics (RNAZ) Stock Down 62% Today?
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    TransCode Therapeutics, Inc. Announces Pricing of Public Offering
    From TransCode Therapeutics, Inc.
    Via GlobeNewswire
    TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
    From TransCode Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
    From TransCode Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    RNAZ Stock Earnings: TransCode Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
    From TransCode Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.